Representative Director, President, CEO and CSO
Masanori Watanabe
Masanori Watanabe has led numerous projects with wide and abundant experience in nonclinical studies including target hunting and identification. His strengths lie in R&D experience with a wide range of modalities.
He holds an MSc in Medical Science from the University of Tsukuba.
Executive Director, COO, Business Development and Corporate Operation Head
Kenichi Anai
Kenichi Anai has strengths in global licensing and alliance management, including opportunity search and evaluation, contract negotiation as well as management of partnerships.
MSc in Agricultural and Life Sciences from the University of Tokyo.
He holds an MSc in Agricultural and Life Sciences from the University of Tokyo.
Outside Director
Hisashi Mitsuguchi
Senior Investment Manager, DBJ Capital Co., Ltd.
Hisashi Mitsuguchi has been involved in various financing activities for companies and funds in the pharmaceutical, medical device, and medical service sectors at Development Bank of Japan and its venture capital subsidiary, DBJ Capital.
He holds an MSc in Pharmaceutical Sciences from the University of Tokyo.
Full-time, Outside Audit & Supervisory Board Member
Yoshitaka Katayama
Yoshitaka Katayama has over 35 years of experience working in management accounting and auditing at a major Japanese chemical manufacturer, and has held multiple key positions including General Manager of Accounting, Corporate Officer and General Manager of Business Administration, and Corporate Officer and General Manager of Audit. During his time at the company, he was responsible for auditing the entire corporate group and overseeing J-SOX compliance, and also served as a part-time board director and a part-time auditor for the group companies in and outside Japan.
Graduated from the Faculty of Business Administration, Kobe University.
Outside Audit & Supervisory Board Member
Takayuki Oda
Takayuki Oda has been engaged in legal and business administration at a management consulting company, a holding company, and a biotech company.
At the biotech company, he has experienced General Manager of the Legal Department and Executive Officer.
He oversaw legal affairs, IPO, M&As, and equity finance, among other aspects.
Currently, as a lawyer, he is engaged in legal support for listed and unlisted companies and civil cases.
He is a lawyer who has graduated from Doshisha University Faculty of Law and Meijo University (Law School).